Clinical Research, Pharma & Healthcare FinancingAvirmax Begins IND Studies for ABI-201 Gene Therapy for AMDPR NewswireMarch 3, 2025March 4, 2025 by PR NewswireMarch 3, 2025March 4, 20250132 Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the commencement of Investigational New Drug (IND)-enabling studies of...